Trial to Promote Recovery From COVID-19 With Endocrine Therapy

Summary

Patients with COVID-19 requiring inpatient hospitalization will be randomized to treatment with standard of care or standard of care + bicalutamide. This will be a randomized, open-label study to determine if bicalutamide improves the rate of clinical improvement in patients with COVID-19.

Timeline

Start

2021-04

Primary completion

2022-01

Completion

2022-01

Drugs

Indications